Last updated 2026-06-18
- Raised $565k funding round, Jan 2022
- Raised $4M grant, Jan 2021
- Raised $3M grant, Sep 2020
Total raised
$11.1M
Last: 2024-02
Stage
Series A
Founded
2015
Headcount
10
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences
About
Betalin Therapeutics seeks to eliminate the need for insulin injections and glucose testing in diabetes patients with its proprietary transplanted Engineered Micro Pancreas (EMP). The EMP technology helps create connective tissue that enables the body's beta cells to function properly and produce adequate and functional insulin.
Betalin Therapeutics licensed the novel EMP technology developed at the Hebrew University of Jerusalem, Israel, in an exclusive worldwide agreement in 2015. The Hebrew University continues to partner with Betalin Therapeutics to support the research and development.
Funding history · 6 rounds · $11.1M total
2024-02
Undisclosed
2022-01
2021-01
Grant
$4.0M
2020-09
Grant
$3.0M
2019-04
$2.5M
2016-01
Grant
$1.0M
Q&A
- What is Betalin Therapeutics' primary focus?
- Betalin Therapeutics focuses on tissue engineering to provide an alternative to insulin therapy, aiming to eliminate the need for insulin injections and glucose testing in diabetes patients.
- What is Betalin Therapeutics' core technology?
- Betalin Therapeutics' core technology is the proprietary transplanted Engineered Micro Pancreas (EMP), which helps create connective tissue to enable beta cells to function properly and produce insulin.
- When was Betalin Therapeutics founded?
- Betalin Therapeutics was founded in July 2015.
- How many employees does Betalin Therapeutics have?
- Betalin Therapeutics has 1-10 employees.
- What was Betalin Therapeutics' most recent funding activity?
- In February 2024, Betalin Therapeutics received funding from Together We Invest.
- What was the total amount raised by Betalin Therapeutics?
- Betalin Therapeutics has raised a total of $11,065,000 USD.
- Which organizations have provided grants to Betalin Therapeutics?
- Betalin Therapeutics has received grants from the Office of the Chief Scientist, EU Horizon 2020, and the European Innovation Council (EIC).
- Who are the co-founders of Betalin Therapeutics?
- The co-founders of Betalin Therapeutics are Shuki Joshua Hershcovich and Shay Hershcovich.
- What is Betalin Therapeutics' current product stage?
- Betalin Therapeutics' product is currently in the clinical trial stage.
Team · 2
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyBiomaterials & Tissue Engineering
Technologies
Materials & SubstancesImplantsBiologicalsCells
Target customers
Healthcare & Life SciencesHealthcareProvidersPatients
Business model
B2B2C
Highlights
1 PatentsVerified
Tags
bioconvergencediabetescell-therapybiological-therapyregenerative-medicinebiopharmaceuticalbiotechnologychronic-patientstreatments
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | betalintherapeutics.com |
|---|---|
| linkedin.com/company/10782073 | |
| facebook.com/Betalin.Therapeutics.Inc | |
| YouTube | youtube.com/channel/UCvGtq0FUKMyK6n0s1F4jZrA |
Identifiers & details
| Founded | 2015-7 |
|---|---|
| Employees (exact) | 10 |
| Offices | Ramat Gan |
Radar intelligence
Patents
| EPO | 2 |
|---|
Web history (Wayback)
| Domain | betalintherapeutics.com |
|---|
Certificate / subdomain footprint
| Subdomains | 3 |
|---|